Abstract
摘要
相似文献
1
T1G3: What to do?
Arch Ital Urol Androl. 1996 Feb;68(1):5-7.
2
The optimal management of T1G3 bladder cancer.
BJU Int. 2008 Nov;102(9 Pt B):1265-73. doi: 10.1111/j.1464-410X.2008.07969.x.
3
T1 and T2 bladder cancer: selecting optimal therapy.
Eur Urol. 1998;33 Suppl 4:16-7. doi: 10.1159/000052256.
4
[T1G3 bladder tumors: 5 years later].
Arch Ital Urol Androl. 1996 Feb;68(1):35-8.
5
T1G3 bladder cancer--the case for TUR and BCG.
Front Radiat Ther Oncol. 2002;36:147-50. doi: 10.1159/000061336.
6
[Conservative treatment of high-risk (T1G3) transitional carcinoma].
Arch Ital Urol Androl. 1996 Feb;68(1):21-4.
7
[T1G3 bladder tumors: our experience].
Arch Ital Urol Androl. 1996 Feb;68(1):39-45.
8
[pT1G3 bladder carcinoma: our experience].
Arch Ital Urol Androl. 1996 Feb;68(1):9-11.
9
[T1G3 bladder neoplasms: treatment and results].
Arch Ital Urol Androl. 1996 Feb;68(1):47-50.
10
[pT1G3 bladder carcinoma: parameters of a correct therapy].
Arch Ital Urol Androl. 1996 Feb;68(1):17-20.
Zotero 插件